Literature DB >> 23219550

T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures.

Marion Kennedy1, Geneve Awong, Christopher M Sturgeon, Andrea Ditadi, Ross LaMotte-Mohs, Juan Carlos Zúñiga-Pflücker, Gordon Keller.   

Abstract

The efficient generation of hematopoietic stem cells from human pluripotent stem cells is dependent on the appropriate specification of the definitive hematopoietic program during differentiation. In this study, we used T lymphocyte potential to track the onset of definitive hematopoiesis from human embryonic and induced pluripotent stem cells differentiated with specific morphogens in serum- and stromal-free cultures. We show that this program develops from a progenitor population with characteristics of hemogenic endothelium, including the expression of CD34, VE-cadherin, GATA2, LMO2, and RUNX1. Along with T cells, these progenitors display the capacity to generate myeloid and erythroid cells. Manipulation of Activin/Nodal signaling during early stages of differentiation revealed that development of the definitive hematopoietic progenitor population is not dependent on this pathway, distinguishing it from primitive hematopoiesis. Collectively, these findings demonstrate that it is possible to generate T lymphoid progenitors from pluripotent stem cells and that this lineage develops from a population whose emergence marks the onset of human definitive hematopoiesis.
Copyright © 2012 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23219550     DOI: 10.1016/j.celrep.2012.11.003

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  183 in total

1.  New markers for tracking endoderm induction and hepatocyte differentiation from human pluripotent stem cells.

Authors:  Audrey Holtzinger; Philip R Streeter; Farida Sarangi; Scott Hillborn; Maryam Niapour; Shinichiro Ogawa; Gordon Keller
Journal:  Development       Date:  2015-10-22       Impact factor: 6.868

Review 2.  Understanding platelet generation from megakaryocytes: implications for in vitro-derived platelets.

Authors:  Xiuli Sim; Mortimer Poncz; Paul Gadue; Deborah L French
Journal:  Blood       Date:  2016-01-19       Impact factor: 22.113

Review 3.  Generating human hematopoietic stem cells in vitro -exploring endothelial to hematopoietic transition as a portal for stemness acquisition.

Authors:  Igor I Slukvin
Journal:  FEBS Lett       Date:  2016-07-22       Impact factor: 4.124

Review 4.  Humanized mice for immune checkpoint blockade in human solid tumors.

Authors:  Henry Yip; Carl Haupt; Grace Maresh; Xin Zhang; Li Li
Journal:  Am J Clin Exp Urol       Date:  2019-10-15

5.  Human definitive hematopoietic specification from pluripotent stem cells is regulated by mesodermal expression of CDX4.

Authors:  J Philip Creamer; Carissa Dege; Qihao Ren; Jolie T K Ho; Mark C Valentine; Todd E Druley; Christopher M Sturgeon
Journal:  Blood       Date:  2017-04-13       Impact factor: 22.113

Review 6.  Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells.

Authors:  Igor I Slukvin
Journal:  Blood       Date:  2013-10-11       Impact factor: 22.113

7.  Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo.

Authors:  Zhenya Ni; David A Knorr; Laura Bendzick; Jeremy Allred; Dan S Kaufman
Journal:  Stem Cells       Date:  2014-04       Impact factor: 6.277

8.  NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells.

Authors:  Akhilesh Kumar; Jeong Hee Lee; Kran Suknuntha; Saritha S D'Souza; Abir S Thakur; Igor I Slukvin
Journal:  J Immunol       Date:  2018-12-21       Impact factor: 5.422

9.  Using induced human pluripotent stem cells to study Diamond-Blackfan anemia: an outlook on the clinical possibilities.

Authors:  Philip J Mason; Nieves Perdigones; Monica Bessler
Journal:  Expert Rev Hematol       Date:  2013-12       Impact factor: 2.929

Review 10.  De novo generation of HSCs from somatic and pluripotent stem cell sources.

Authors:  Linda T Vo; George Q Daley
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.